Patents by Inventor Gary Brandt

Gary Brandt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11858943
    Abstract: Compounds are provided that antagonize vasopressin receptors, particularly the V1a receptor products containing such compounds, as well as to methods of their use and synthesis. Such compounds have the structure of Formula (I), or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof: wherein A, B, G, R1, R1b, R1c, R2 and X are as defined herein.
    Type: Grant
    Filed: October 13, 2021
    Date of Patent: January 2, 2024
    Assignee: NEUMORA THERAPEUTICS, INC.
    Inventors: Robert M. Jones, Mariangela Urbano, Gary Brandt, David Hardick, Chris Knight, Jason Tierney
  • Publication number: 20230093235
    Abstract: Compounds are provided that antagonize vasopressin receptors, particularly the V1a receptor products containing such compounds, as well as to methods of their use and synthesis. Such compounds have the structure of Formula (I), or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof: wherein A, B, G, R1, R1b, R1c, R2 and X are as defined herein.
    Type: Application
    Filed: October 13, 2021
    Publication date: March 23, 2023
    Inventors: Robert M. Jones, Mariangela Urbano, Gary Brandt, David Hardick, Chris Knight, Jason Tierney
  • Publication number: 20230084719
    Abstract: The present invention relates to 1-(2,6-diazaspiro[3.3]heptan-6-yl)-5,6-dihydro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine derivatives and related compounds of Formula (I): wherein A, B, G, R1, R1b, R1C, R2 and X are as defined herein. The present compounds are vasopressin receptor antagonists (in particular of the Via receptor) for the treatment of neuro-psychological disorders, such as e.g. autism, anxiety, stress-related disorders, depression, schizophrenia or bipolar disorder. The present description discloses the synthesis of exemplary compounds, as well as pharmacological data thereof (e.g. pages 71 to 246; examples 1 to 49; tables 1 to 5). An exemplary compound is e.g. 8-chloro-1-(2-(5-fluoropyridin-2-yl)-2,6-diazaspiro[3.3]heptan-6-yl)-5-methyl-5,6-dihydro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine (example 1, compound no. 1).
    Type: Application
    Filed: December 12, 2019
    Publication date: March 16, 2023
    Inventor: Gary Brandt
  • Patent number: 11186577
    Abstract: Compounds are provided that antagonize vasopressin receptors, particularly the V1a receptor products containing such compounds, as well as to methods of their use and synthesis. Such compounds have the structure of Formula (I), or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof: wherein A, B, G, R1, R1b, R1c, R2 and X are as defined herein.
    Type: Grant
    Filed: June 5, 2018
    Date of Patent: November 30, 2021
    Assignee: BLACKTHORN THERAPEUTICS, INC.
    Inventors: Robert M. Jones, Mariangela Urbano, Gary Brandt, David Hardick, Chris Knight, Jason Tierney
  • Publication number: 20210317126
    Abstract: Compounds are provided that antagonize vasopressin receptors, particularly the V1a receptor products containing such compounds, as well as to methods of their use and synthesis. Such compounds have the structure of Formula (I), or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof: wherein Q1, Q2, Q3, R2a, R2b, R3 and X are as defined herein.
    Type: Application
    Filed: March 5, 2021
    Publication date: October 14, 2021
    Inventors: Robert M. Jones, Mariangela Urbano, Gary Brandt, Mark Chambers, David Hardick, Chris Knight, Jason Tierney, Chris Lock
  • Patent number: 10538530
    Abstract: Compounds are provided that antagonize vasopressin receptors, particularly the V1a receptor products containing such compounds, as well as to methods of their use and synthesis. Such compounds have the structure of Formula (I), or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof: wherein Q1, Q2, Q3, R2a, R2b, R3 and X are as defined herein.
    Type: Grant
    Filed: September 5, 2018
    Date of Patent: January 21, 2020
    Assignee: BlackThorn Therapeutics, Inc.
    Inventors: Robert M. Jones, Mariangela Urbano, Gary Brandt, Mark Chambers, David Hardick, Chris Knight, Jason Tierney, Chris Lock
  • Publication number: 20190169202
    Abstract: Compounds are provided that antagonize vasopressin receptors, particularly the V1a receptor products containing such compounds, as well as to methods of their use and synthesis. Such compounds have the structure of Formula (I), or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof: wherein Q1, Q2, Q3, R2a, R2b, R3 and X are as defined herein.
    Type: Application
    Filed: September 5, 2018
    Publication date: June 6, 2019
    Inventors: Robert M. Jones, Mariangela Urbano, Gary Brandt, Mark Chambers, David Hardick, Chris Knight, Jason Tierney, Chris Lock
  • Publication number: 20190048013
    Abstract: Compounds are provided that antagonize vasopressin receptors, particularly the V1a receptor products containing such compounds, as well as to methods of their use and synthesis. Such compounds have the structure of Formula (I), or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof: wherein A, B, G, R1, R1b, R1c, R2 and X are as defined herein.
    Type: Application
    Filed: June 5, 2018
    Publication date: February 14, 2019
    Inventors: Robert M. Jones, Mariangela Urbano, Gary Brandt, David Hardick, Chris Knight, Jason Tierney
  • Patent number: 8152650
    Abstract: An adjustable golf swing practice device adapted for engaging a knee or calf muscle of a back leg of a golfer and preventing body sway during a golf club back swing. The practice device includes an adjustable leg brace for engaging the outside of the knee or calf muscle to help encourage and maintain knee flex and prevent the straightening or locking of the back leg during a club back swing. The leg brace is attached to an adjustable leg brace pole having a telescoping rod and an outer tube for adjusting the length of the pole for different heights of golfers. The outer tube is pivotally mounted on a leg brace pole housing with housing base. The housing base includes a horizontal shoe extension, which is used for receiving the golfer's shoe thereon and holding the practice device in place during practice.
    Type: Grant
    Filed: April 7, 2011
    Date of Patent: April 10, 2012
    Inventor: Gary Brandt
  • Patent number: 6701355
    Abstract: An insertion and encoder system monitors broadcasts from a first broadcasting system to determine the presence of segments that can be substituted in a second broadcast. In one embodiment, the system and method determines whether the first segment from the first broadcast had been sold for the second broadcasting system. In this example embodiment, if the first segment had not been sold for the second broadcasting system, it is substituted for a second segment. The system and method accesses an inventory of sold substitution segments and substitutes a sold segment for the unsold segment in real time. In one embodiment, sold advertisement segments are substituted for unsold advertisement segments that are broadcast to a wide audience over the Internet. Segments are selected in accordance with predefined criteria that can include user demographics and/or personal preferences.
    Type: Grant
    Filed: September 29, 1999
    Date of Patent: March 2, 2004
    Assignee: Susquehanna Media Co.
    Inventors: Gary A. Brandt, Donald R. Largen, Wayne F. Cummings
  • Patent number: 6587827
    Abstract: A method and system for processing a customer generated order for a product, more particularly to a method for one or more client computers connected through a server to a plurality of supplier computers to fulfill a customer generated order. The method includes the client creating an order event with a preferred supplier, the server routing the order event to the preferred supplier, the server monitoring status of the order event from the preferred supplier, the preferred supplier processing the order event, and the server periodically synchronizing inventory between the client and all suppliers.
    Type: Grant
    Filed: October 22, 1999
    Date of Patent: July 1, 2003
    Assignee: Hewlett-Packard Development Company, L.P.
    Inventors: Carole Hennig, Melody Peters, Carolyn M. Nickey, Gary Brandt, Eric Price, Marjorie Sladek
  • Patent number: 6458041
    Abstract: A golf ball putting device used by a golfer to practice a line of sight directly over the top center of a golf ball when putting the ball. By practicing with the device, the golfer enhances his or her skill in alignment of sight over the top of the golf ball with improved putting skills. The golf ball putting device includes an upright support having a vertical lower portion, a curved middle portion and a horizontal upper portion. The lower portion can be inserted into a ground surface or inserted into a stand. The upper portion includes a forked end. The forked end includes a first fork arm and a second fork arm with an eye alignment opening therebetween. Ends of the first fork arm and the second fork arm are joined together by an elongated upper sight alignment member. The upper sight alignment member, when properly positioned, is parallel to the direction of travel of the golf ball when it is putted. Suspended from opposite ends of the upper sight alignment member are a pair of suspension chains.
    Type: Grant
    Filed: November 9, 2000
    Date of Patent: October 1, 2002
    Inventor: Gary Brandt